Nasdaq
MESO
Mesoblast Limited
- Health Care
- Australia
- Listed 2015
- 1 day
- +4.4%
- 1 month
- +9.3%
- 1 year
- −0.3%
$15.62 · Mkt cap $2.02B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Mesoblast Limited
$15.62 · Mkt cap $2.02B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Mesoblast Limited trades under the ticker MESO on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2015. Its market capitalisation is $2.02B. The last closing price was $15.62, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −0.3%, and +9.3% over the past month. Returns are price returns and exclude dividends.
This page exists because MESO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.